Allergen-specific immunotherapy and evidence: A European regulatory perspective.

Bartel D, Bonertz A, Hartenstein D, Kaul S, Lauer I, Reeb C, Rösner-Friese K, Sliva K, Zimmer J, Vieths S, Mahler V

Open source

DOI
10.5414/alx02413e
Published
2023
Container
Allergologie select
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5414/alx02413e,
  title = {Allergen-specific immunotherapy and evidence: A European regulatory perspective.},
  author = {Bartel D and Bonertz A and Hartenstein D and Kaul S and Lauer I and Reeb C and Rösner-Friese K and Sliva K and Zimmer J and Vieths S and Mahler V},
  year = {2023},
  journal = {Allergologie select},
  doi = {10.5414/alx02413e},
  url = {https://doi.org/10.5414/alx02413e}
}

RIS

TY  - JOUR
TI  - Allergen-specific immunotherapy and evidence: A European regulatory perspective.
AU  - Bartel D
AU  - Bonertz A
AU  - Hartenstein D
AU  - Kaul S
AU  - Lauer I
AU  - Reeb C
AU  - Rösner-Friese K
AU  - Sliva K
AU  - Zimmer J
AU  - Vieths S
AU  - Mahler V
PY  - 2023
JO  - Allergologie select
DO  - 10.5414/alx02413e
UR  - https://doi.org/10.5414/alx02413e
ER  - 

APA

D, B., A, B., D, H., S, K., I, L., C, R., K, R., K, S., J, Z., S, V., & V, M. (2023). Allergen-specific immunotherapy and evidence: A European regulatory perspective.. Allergologie select. https://doi.org/10.5414/alx02413e

Source records